Adili, Asiguli
Aikemu, Maihesumu
Rana, Karanvir Singh
Wei, Yihan
Yusufu, Aibibai
Jiang, Sheng
Funding for this research was provided by:
The Xinjiang Uygur Autonomous Region Science and Technology Innovation Team (Tianshan Innovation Team) Project (2022TSYCTD0014, 2022TSYCTD0014, 2022TSYCTD0014, 2022TSYCTD0014)
Open Project of the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia (SKL-HIDCA-2024-RWS1, SKL-HIDCA-2024-RWS1, SKL-HIDCA-2024-RWS1, SKL-HIDCA-2024-RWS1)
Article History
Received: 2 February 2025
Accepted: 11 September 2025
First Online: 16 October 2025
Declarations
:
: The authors declare no competing interests.
: This study is a retrospective study and has been approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University. The need for informed consent was waived by the study approving ethics committee.The ethical approval number of the study is K202502-12. The Study complied with the provisions of the Helsinki Declaration(revised in Brazil in 2013).